Key points are not available for this paper at this time.
Mosquitoes and mosquito-borne diseases remain one of the major public health burdens. In most cases, vector control is the main or the only intervention to mitigate these problems. We are facing the challenges of traditional, emerging, or resurging vectors and diseases, yet the availability and affordability of safe and effective mosquito control products are at a historical low. Development of new active ingredients (AI) and novel formulations based on currently available AI are demanded by mosquito control operations. This paper validated the bioactivity in the laboratory and evaluated the semi-field efficacy for 2 newly registered controlled-release products based on juvenile hormone analog S-methoprene: OmniPrene™ water-soluble pouch (WSP) and extended water-soluble pouch (XWSP). Along with technical S-methoprene, these 2 formulations showed high inhibition of adult emergence in laboratory bioassays against Aedes aegypti, Ae. albopictus, and Culex quinquefasciatus that are commonly found in catch basins. High initial and long-term residual efficacy were demonstrated in simulated catch basins against Cx. quinquefasciatus, where the OmniPrene WSP consistently provided over 90% control for 15 wk (105 days) and OmniPrene XWSP did the same for 38 wk (266 days). Considering the need for reliable mosquito control products, combined with commonly encountered product performance issues in catch basins, OmniPrene WSP and XWSP can be viable tools to combat mosquito species of public health concern that are associated with urban drainage systems.
Su et al. (Thu,) studied this question.